𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sargramostim promising for Crohn's disease

Book ID
120849727
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2006
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I trial of sargramostim in pediatr
Phase I trial of sargramostim in pediatric Crohn's disease
✍ Judith R. Kelsen; Joel Rosh; Mel Heyman; Harland S. Winter; George Ferry; Stanle πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 178 KB πŸ‘ 1 views

Background: Improving granulocyte function may represent an effective therapy for Crohn's disease (CD). We performed a Phase I-2 trial of sargramostim (SRG) in children with CD. Methods: This was multicenter, open-label study in 6-16-yearold patients with moderate to severely active CD. Patients re